Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Lambe

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
BMJ Open|July 27, 2016
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementationDavid Weller, Peter Vedsted, Chantelle Anandan, et al.
International Journal of Cancer|April 14, 2022
The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020Anna L V Johansson, Siri Larønningen, Charlotte Wessel Skovlund, et al.
The Lancet Regional Health. Europe|August 7, 2023
Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination eraAnna L V Johansson, Anna Skog, Tom Børge Johannesen, et al.
Cancer Epidemiology|January 15, 2019
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictionsMichael Eden, Samantha Harrison, Michelle Griffin, et al.
BMJ Open|December 15, 2022
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry dataPeter Vedsted, David Weller, Alina Zalounina Falborg, et al.
Acta Oncologica (Stockholm, Sweden)|February 12, 2025
Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countriesAnna Johansson, Anna Skog, Tom Børge Johannesen, et al.
Breast Cancer Research : BCR|December 2, 2016
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohortsChris R Cardwell, Anton Pottegård, Evelien Vaes, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2024
Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021Anna L V Johansson, Simon M Kønig, Siri Larønningen, et al.
JCI Insight|October 5, 2016
Profiling cancer testis antigens in non-small-cell lung cancerDijana Djureinovic, Björn M Hallström, Masafumi Horie, et al.
BMJ Open|November 29, 2018
Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP)David Weller, Usha Menon, Alina Zalounina Falborg, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
BMJ Open|July 27, 2016
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementationDavid Weller, Peter Vedsted, Chantelle Anandan, et al.
International Journal of Cancer|April 14, 2022
The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020Anna L V Johansson, Siri Larønningen, Charlotte Wessel Skovlund, et al.
The Lancet Regional Health. Europe|August 7, 2023
Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination eraAnna L V Johansson, Anna Skog, Tom Børge Johannesen, et al.
Cancer Epidemiology|January 15, 2019
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictionsMichael Eden, Samantha Harrison, Michelle Griffin, et al.
BMJ Open|December 15, 2022
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry dataPeter Vedsted, David Weller, Alina Zalounina Falborg, et al.
Acta Oncologica (Stockholm, Sweden)|February 12, 2025
Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countriesAnna Johansson, Anna Skog, Tom Børge Johannesen, et al.
Breast Cancer Research : BCR|December 2, 2016
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohortsChris R Cardwell, Anton Pottegård, Evelien Vaes, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2024
Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021Anna L V Johansson, Simon M Kønig, Siri Larønningen, et al.
JCI Insight|October 5, 2016
Profiling cancer testis antigens in non-small-cell lung cancerDijana Djureinovic, Björn M Hallström, Masafumi Horie, et al.
BMJ Open|November 29, 2018
Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP)David Weller, Usha Menon, Alina Zalounina Falborg, et al.
Pageof 23